1.
Köhnke T, Bücklein V, Rechkemmer S, Schneider S, Rothenberg-Thurley M, Metzeler KH, Sauerland M-C, Hiddemann W, Spiekermann K, Subklewe M. Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-induction. Haematologica [Internet]. 2019Oct.30 [cited 2026Nov.16];104(11):e510-e513. Available from: https://haematologica.org/article/view/9140